ACE and systemic sclerosis: The latter analysis on KYNA revealed significant differences between SSc patients who use ACE inhibitors and those who do not use ACE inhibitors (MD = 9.30; p = 0.02; 95%CI [1.37; 17.19], Figure 3B).